JP2007535502A5 - - Google Patents

Download PDF

Info

Publication number
JP2007535502A5
JP2007535502A5 JP2007503102A JP2007503102A JP2007535502A5 JP 2007535502 A5 JP2007535502 A5 JP 2007535502A5 JP 2007503102 A JP2007503102 A JP 2007503102A JP 2007503102 A JP2007503102 A JP 2007503102A JP 2007535502 A5 JP2007535502 A5 JP 2007535502A5
Authority
JP
Japan
Prior art keywords
tetracycline
cmt
pharmaceutical composition
antibacterial
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007503102A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007535502A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/008387 external-priority patent/WO2005089259A2/en
Publication of JP2007535502A publication Critical patent/JP2007535502A/ja
Publication of JP2007535502A5 publication Critical patent/JP2007535502A5/ja
Pending legal-status Critical Current

Links

JP2007503102A 2004-03-12 2005-03-11 非抗菌性テトラサイクリン製剤による大動脈弁狭窄症の治療方法 Pending JP2007535502A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55277904P 2004-03-12 2004-03-12
PCT/US2005/008387 WO2005089259A2 (en) 2004-03-12 2005-03-11 Method for treating aortic stenosis with non-antibacterial tetracycline formulations

Publications (2)

Publication Number Publication Date
JP2007535502A JP2007535502A (ja) 2007-12-06
JP2007535502A5 true JP2007535502A5 (https=) 2008-05-01

Family

ID=34994224

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007503102A Pending JP2007535502A (ja) 2004-03-12 2005-03-11 非抗菌性テトラサイクリン製剤による大動脈弁狭窄症の治療方法

Country Status (10)

Country Link
US (1) US20100137261A1 (https=)
EP (1) EP1729752A4 (https=)
JP (1) JP2007535502A (https=)
KR (1) KR20060130205A (https=)
CN (1) CN101420960A (https=)
AU (1) AU2005222937B2 (https=)
CA (1) CA2558015A1 (https=)
MX (1) MXPA06010404A (https=)
NZ (1) NZ549678A (https=)
WO (1) WO2005089259A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8012950B2 (en) * 2003-08-29 2011-09-06 Wisconsin Alumni Research Foundation Method to diagnose and treat degenerative joint disease
GB201610400D0 (en) 2016-06-15 2016-07-27 Cambridge Entpr Ltd And Kings College London Vascular calcification

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1494681A4 (en) * 2002-04-16 2008-08-06 Collagenex Pharm Inc PROCESS FOR THE SIMULTANEOUS TREATMENT OF OCULAR ROSACEA AND ACNE ROSACEA
JP2005526114A (ja) * 2002-05-06 2005-09-02 コッラジェネックス ファーマシューチカルス インコーポレイテッド 粘膜炎及び真菌感染症の同時治療方法

Similar Documents

Publication Publication Date Title
JP2007510757A5 (https=)
AU2002256092B2 (en) Controlled delivery of tetracycline compounds and tetracycline derivatives
US20260015317A1 (en) Substituted tetracycline compounds for treatment of inflammatory skin disorders
JP2005523313A5 (https=)
HRP20210670T1 (hr) Pripravci za liječenje raka
AU2007208214B2 (en) Methods of increasing oral bioavailability of tetracyclines
AU2002256092A1 (en) Controlled delivery of tetracycline compounds and tetracycline derivatives
ES2255107T3 (es) Fomento de la cicatrizacion de heridas mediante tetraciclinas modificadas quimicamente.
CA2485677A1 (en) Methods of treating allergic reactions
CY1118519T1 (el) Συνθεση τετρακυκλινων και αναλογων αυτων
CA2440472A1 (en) Methods of treating acne
JP2007535502A5 (https=)
JP2005533110A5 (https=)
Lacerda-Santos et al. Effect of Different Concentrations of Chlorhexidine in Glass-ionomer Cements on In Vivo Biocompatibility.
AU759372B2 (en) A novel inhibitor of cataract formation
EP1648531A1 (de) Verwendung von antiseptischen wirkstoffen in pmma-knochenzementen
JP2005521701A5 (https=)
EP2250887A3 (en) Use of non-antibacterial tetracycline analog CMT-1002 and formulations thereof for the treatment of bacterial exotoxins
DE102008046610A1 (de) Verwendung einer pharmazeutischen Zusammensetzung zur lokalen Infektionstherapie sowie Medizinprodukt
Suchetha et al. Chemically Modified Tetracyclines: A Review
NZ538198A (en) Method for reducing C-reactive protein (CRP) levels by administering a non-antibacterial tetracycline formulation or a low dose of an antibacterial tetracycline formulation
MXPA06010404A (es) Metodo para tratar la estenosis aortica con formulaciones de tetraciclina no anti-bacterianas.
AU2018303807B2 (en) Treatment of non-inflammatory lesions
WO2024015857A3 (en) Modified caveolin-1 peptide formulations and methods of manufacturing and use thereof
BR102020003535A2 (pt) Elásticos ortodônticos modificados para a liberação controlada de agentes antimicrobianos e flavorizantes